Amalgamated Bank Seelos Therapeutics, Inc. Transaction History

Amalgamated Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.51 - $0.93 $8,156 - $14,874	-15,994 Closed	0 $0
Q1 2022 Jun 30, 2022	SELL	$0.84 - $1.71 $1,031 - $2,099	-1,228 Reduced 7.13%	15,994 $13,000
Q4 2021 Feb 15, 2022	BUY	$1.59 - $2.38 $3,499 - $5,238	2,201 Added 14.65%	17,222 $28,000
Q3 2021 Oct 29, 2021	BUY	$1.69 - $2.89 $1,189 - $2,034	704 Added 4.92%	15,021 $36,000
Q2 2021 Aug 16, 2021	BUY	$2.64 - $6.32 $37,796 - $90,483	14,317 New	14,317 $38,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $32M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.